Salvage stereotactic reirradiation with or without cetuximab for locally recurrent head-and-neck cancer: A feasibility study

International Journal of Radiation Oncology Biology Physics

Volumn 84, Issue 1, 2012, Pages 203-209

  Comet, Bénédicte ^a   Kramar, Andrew ^a   Faivre Pierret, Mathieu ^a   Dewas, Sylvain ^a   Coche Dequeant, Bernard ^a   Degardin, Marian ^a   Lefebvre, Jean Louis ^a   Lacornerie, Thomas ^a   Lartigau, Eric F ^a  

^a CENTRE OSCAR LAMBRET   (France)

Author keywords

Head and neck tumors; Re irradiation; Recurrence; Stereotactic radiotherapy

Indexed keywords

ACUTE TOXICITY; CETUXIMAB; CIS-PLATIN; CRITICAL STRUCTURES; FEASIBILITY STUDIES; HEAD-AND-NECK CANCER; HEAD-AND-NECK TUMOR; HEALTHY TISSUES; IRRADIATED AREA; NORMAL TISSUE; OVERALL SURVIVAL; PARTIAL RESPONSE; PHASE II; PLANNING TARGET VOLUMES; RECURRENCE; REIRRADIATION; RESPONSE RATE; SALVAGE TREATMENT; SQUAMOUS CELL CARCINOMA; STEREOTACTIC BODY RADIOTHERAPY; STEREOTACTIC RADIOTHERAPY; TOLERANCE LIMITS; TUMOR RESPONSE; TUMOR SIZE;

DISEASES; HISTOLOGY; IRRADIATION; PLANNING; PLATINUM COMPOUNDS; RADIOTHERAPY; SURVEYS; TOXICITY; TUMORS;

DIAGNOSIS;

CETUXIMAB; CISPLATIN;

ADULT; AGED; ARTICLE; ASTHENIA; CANCER PROGNOSIS; CLINICAL ARTICLE; DRUG ERUPTION; DYSPHAGIA; ERYTHEMA; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; MALE; MUCOSA INFLAMMATION; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RASH; RECURRENT CANCER; RECURRENT DISEASE; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT PLANNING; TREATMENT RESPONSE; TUMOR VOLUME; VOMITING; XEROSTOMIA;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DISEASE-FREE SURVIVAL; FEASIBILITY STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; RADIOSURGERY; RADIOTHERAPY DOSAGE; RETREATMENT; SALVAGE THERAPY; TUMOR BURDEN; YOUNG ADULT;

EID: 84862173680     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.11.054     Document Type: Article

References (40)

1. G. Calais, E. Bardet, and C. Sire Radiotherapy with concomitant weekly docetaxel for Stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trial Int J Radiat Oncol Biol Phys 58 2004 161 166
2. A.A. Forastiere, H. Goepfert, and M. Maor Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N Engl J Med 349 2003 2091 2098
3. J.L. Lefebvre, D. Chevalier, and B. Luboinski Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group J Natl Cancer Inst 88 1996 890 899
4. M. Pernot, L. Malissard, and S. Hoffstetter The study of tumoral, radiobiological, and general health factors that influence results and complications in a series of 448 oral tongue carcinomas treated exclusively by irradiation Int J Radiat Oncol Biol Phys 29 1994 673 679
5. D. Taussky, P. Dulguerov, and A.S. Allal Salvage surgery after radical accelerated radiotherapy with concomitant boost technique for head and neck carcinomas Head Neck 27 2005 182 186
6. S. Temam, E. Pape, and F. Janot Salvage surgery after failure of very accelerated radiotherapy in advanced head-and-neck squamous cell carcinoma Int J Radiat Oncol Biol Phys 62 2005 1078 1083
7. J.A. Bonner, P.M. Harari, and J. Giralt Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival Lancet Oncol 11 2010 21 28
8. J.B. Vermorken, R. Mesia, and F. Rivera Platinum-based chemotherapy plus cetuximab in head and neck cancer N Engl J Med 359 2008 1116 1127
9. O. Riesterer, K.A. Mason, and U. Raju Enhanced response to C225 of A431 tumor xenografts growing in irradiated tumor bed Radiother Oncol 92 2009 383 387
10. A.A. Forastiere, T. Leong, and E. Rowinsky Phase III comparison of high-dose paclitaxel + cisplatin + granulocyte colony-stimulating factor versus low-dose paclitaxel + cisplatin in advanced head and neck cancer: Eastern Cooperative Oncology Group Study E1393 J Clin Oncol 19 2001 1088 1095
11. A.A. Forastiere, B. Metch, and D.E. Schuller Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: A Southwest Oncology Group study J Clin Oncol 10 1992 1245 1251
12. M.K. Gibson, Y. Li, and B. Murphy Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): An intergroup trial of the Eastern Cooperative Oncology Group J Clin Oncol 23 2005 3562 3567
13. D. Soulieres, N.N. Senzer, and E.E. Vokes Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck J Clin Oncol 22 2004 77 85
14. D. Langlois, S. Hoffstetter, and L. Malissard Salvage irradiation of oropharynx and mobile tongue about 192 iridium brachytherapy in Centre Alexis Vautrin Int J Radiat Oncol Biol Phys 14 1988 849 853
15. P.C. Levendag, C.A. Meeuwis, and A.G. Visser Reirradiation of recurrent head and neck cancers: External and/or interstitial radiation therapy Radiother Oncol 23 1992 6 15
16. J.S. Low, E.T. Chua, and F. Gao Stereotactic radiosurgery plus intracavitary irradiation in the salvage of nasopharyngeal carcinoma Head Neck 28 2006 321 329
17. R. Martinez-Monge, J. Alcalde, and C. Concejo Perioperative high-dose-rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Initial results of a Phase I/II reirradiation study Brachytherapy 5 2006 32 40
18. D. Peiffert, M. Pernot, and L. Malissard Salvage irradiation by brachytherapy of velotonsillar squamous cell carcinoma in a previously irradiated field: Results in 73 cases Int J Radiat Oncol Biol Phys 29 1994 681 686
19. E.E. Vokes, and I. Athanasiadis Chemotherapy of squamous cell carcinoma of head and neck: The future is now Ann Oncol 7 1996 15 29
20. R. De Crevoisier, J. Bourhis, and C. Domenge Full-dose reirradiation for unresectable head and neck carcinoma: Experience at the Gustave-Roussy Institute in a series of 169 patients J Clin Oncol 16 1998 3556 3562
21. J.K. Salama, E.E. Vokes, and S.J. Chmura Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma Int J Radiat Oncol Biol Phys 64 2006 382 391
22. S.A. Spencer, J. Harris, and R.H. Wheeler Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck Head Neck 30 2008 281 288
23. C.J. Langer, J. Harris, and E.M. Horwitz Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: Results of Radiation Therapy Oncology Group Protocol 9911 J Clin Oncol 25 2007 4800 4805
24. R. De Crevoisier, C. Domenge, and P. Wibault Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma Cancer 91 2001 2071 2076
25. F. Janot, D. De Rancourt, and M. Castaing Re-irradiation combined with chemotherapy after salvage surgery in head and neck carcinoma: A randomized trial from GETTEC and GORTEC groups J Clin Oncol 26 2008 5518 5523
26. E.P. Sulman, D.L. Schwartz, and T.T. Le IMRT reirradiation of head and neck cancer - disease control and morbidity outcomes Int J Radiat Oncol Biol Phys 73 2009 399 409
27. N. Lee, K. Chan, and J.E. Bekelman Salvage re-irradiation for recurrent head and neck cancer Int J Radiat Oncol Biol Phys 68 2007 731 740
28. P.C. Pai, C.C. Chuang, and K.C. Wei Stereotactic radiosurgery for locally recurrent nasopharyngeal carcinoma Head Neck 24 2002 748 753
29. D.T. Chua, W.I. Wei, and J.S. Sham Stereotactic radiosurgery versus gold grain implantation in salvaging local failures of nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 69 2007 469 474
30. S.X. Wu, D.T. Chua, and M.L. Deng Outcome of fractionated stereotactic radiotherapy for 90 patients with locally persistent and recurrent nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 69 2007 761 769
31. G. Voynov, D.E. Heron, and S. Burton Frameless stereotactic radiosurgery for recurrent head and neck carcinoma Technol Cancer Res Treat 5 2006 529 535
32. K.W. Roh, J.S. Jang, and M.S. Kim Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer Int J Radiat Oncol Biol Phys 74 2009 1348 1355
33. K.R. Unger, C.E. Lominska, and J.F. Deeken Fractionated stereotactic radiosurgery for reirradiation of head-and-neck cancer Int J Radiat Oncol Biol Phys 74 2010 1411 1419
34. J.A. Bonner, P.M. Harari, and J. Giralt Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 2006 567 578
35. T.Y. Seiwert, D.J. Haraf, and E.E. Cohen Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer J Clin Oncol 26 2008 1732 1741
36. E.E. Cohen, D. Rosine, and D.J. Haraf Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer Int J Radiat Oncol Biol Phys 67 2007 678 684
37. P. Balermpas, M. Hambek, and O. Seitz Combined cetuximab and reirradiation for locoregional recurrent and inoperable squamous cell carcinoma of the head and neck Strahlenther Onkol 185 2009 775 781
38. D.E. Heron, J.C. Rwigema, and M.K. Gibson Concurrent cetuximab with stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: A single institution matched case-control study Am J Clin Oncol 34 2011 165 172
39. M.W. Donald, M.G. Moore, and P.A.S. Johnstone Risk of carotid blowout after reirradiation of the head and neck: A systematic review Int J Radiat Oncol Biol Phys 2011 May 5 (epub ahead of print)
40. M.W. McDonald, J. Lawson, and M.K. Garg ACR appropriateness criteria retreatment of recurrent head and neck cancer after prior definitive radiation Int J Radiat Oncol Biol Phys 80 2011 1292 1298